⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29370717 | 1.00 | — | — | |
| Bromide SCHEMBL28030910 | 0.97 | CA3 (0.46) | — | |
| SCHEMBL3524352 | 0.86 | PTGS2 (0.42) | — | |
| SCHEMBL31633797 | 0.79 | — | — | |
| SCHEMBL18867943 | 0.79 | — | — | |
| SCHEMBL12500 | 0.79 | — | — | |
| SCHEMBL22820004 | 0.78 | ABL1 (0.50) | — | |
| SCHEMBL91411 | 0.77 | — | — | |
| SCHEMBL29367748 | 0.77 | — | — | |
| SCHEMBL60954 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3943 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260058209-A1 | ELECTROLYTE COMPOSITION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY CONTAINING THE SAME | HYUNDAI MOTOR CO LTD (KR) | 2026-02-26 | — | — | US | claimed |
| US-12334502-B2 | Electrolytes for lithium-containing battery cells | APPLE INC. (US) | 2025-06-17 | — | — | US | claimed |
| EP-4399212-A1 | SUBSTITUTED 2,3-DIHYDRO[1,3]THIAZOLO[4,5-B]PYRIDINES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | Bayer Aktiengesellschaft (DE) | 2024-07-17 | — | — | EP | claimed |
| US-12027670-B2 | Non-aqueous electrolyte solution and lithium secondary battery including the same | LG ENERGY SOLUTION, LTD. (KR) | 2024-07-02 | — | — | US | claimed |
| CN-114478345-B | Preparation method of (R) -2- (2, 5-difluorophenyl) pyrrolidine | 中瀚(齐河县)生物医药科技有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-118159542-A | Substituted 2, 3-dihydro [1,3] thiazolo [4,5-b ] pyridines, salts thereof and their use as herbicidal agents | 拜耳公司 | 2024-06-07 | — | — | CN | claimed |
| US-20240136585-A1 | ELECTROLYTES FOR LITHIUM-CONTAINING BATTERY CELLS | APPLE INC. (US) | 2024-04-25 | — | — | US | claimed |
| US-11881558-B2 | Electrolytes for lithium-containing battery cells | APPLE INC. (US) | 2024-01-23 | — | — | US | claimed |
| EP-4273147-A1 | SUBSTITUTED SPIROLACTAMS, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | Bayer Aktiengesellschaft (DE) | 2023-11-08 | — | — | EP | claimed |
| US-20230131260-A1 | SUBSTITUTED THIOPHENYL URACILS, SALTS THEREOF AND THE USE THEREOF AS HERBICIDAL AGENTS | SYNGENTA CROP PROTECTION AG (CH) | 2023-04-27 | — | — | US | claimed |
| WO-2005112145-A1 | SOLUTIONS OF ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2005-11-24 | — | — | WO | claimed |
| WO-2005083814-A1 | SOLUTIONS OF ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2005-09-09 | — | — | WO | claimed |
| US-20040254344-A1 | Amino acid conjugates providing for sustained systemic concentrations of gaba analogues | XENOPORT | 2004-12-16 | — | — | US | claimed |
| US-20040225056-A1 | Solutions and dispersions of organic semiconductors | MERCK PATENT GMBH (DE) | 2004-11-11 | — | — | US | claimed |
| EP-1412324-A4 | AMINO ACID CONJUGATES PROVIDING FOR SUSTAINED SYSTEMIC CONCENTRATIONS OF GABA ANALOGUES | XENOPORT INC (US) | 2004-09-29 | — | — | EP | claimed |
| EP-1412324-A2 | AMINO ACID CONJUGATES PROVIDING FOR SUSTAINED SYSTEMIC CONCENTRATIONS OF GABA ANALOGUES | Xenoport, Inc. (US) | 2004-04-28 | — | — | EP | claimed |
| US-20030181390-A1 | Amino acid conjugates providing for sustained systemic concentrations of GABA analogues | XENOPORT, INC. | 2003-09-25 | — | — | US | claimed |
| WO-2002100344-A2 | AMINO ACID CONJUGATES PROVIDING FOR SUSTAINED SYSTEMIC CONCENTRATIONS OF GABA ANALOGUES | XENOPORT, INC. (US) | 2002-12-19 | — | — | WO | claimed |
| US-6495540-B2 | HEXAHYDROAZEPINE-2-ONE DERIVATIVE AS BETA-AMYLOID INHIBITOR | BRISTOL - MYERS SQUIBB PHARMA COMPANY | 2002-12-17 | — | — | US | claimed |
| US-20020010172-A1 | Lactams as inhibitors of A-beta protein production | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2002-01-24 | — | — | US | claimed |